1. Instructions for Completing CITI Refresher Training
  2. Instructions for Linking Previous CITI Training to Your NetID
  3. Certificate of Confidentiality (CoC) Application Help
  4. Clinical Trials Registration & Results Reporting
  5. Human Subjects Research Protection Program (HRPP) Policy Index
  6. Use of Human Fetal Tissue in Research
  7. Compliance with Human Research Protections in Sponsored Research
  8. Monitoring the Consent Process
  9. Exceptions to Informed Consent Requirements in Emergency Situations
  10. IRB Meetings
  11. Principal Investigator Status for UW–Madison Studies Involving Human Participants
  12. Contact Information for Reporting Suggestions and Concerns
  13. Reporting of Suggestions and Concerns Regarding the Protection of Research Participants
  14. Good Clinical Practice (GCP) Training Guidance and Instructions
  15. UW–Madison Federalwide Assurance (FWA) & IRB Registration Numbers
  16. Engagement in Human Participants Research at UW–Madison
  17. HRPP Guidance, Forms and Resources
  18. Good Clinical Practice (GCP) Refresher Instructions
  19. Initial Review: Submission and Review Policy
  20. IRB Purview
  21. Additional Requirements When Conducting Human Subjects Research with Environmental Protection Agency (EPA) Support
  22. Additional Requirements When Conducting Human Subjects Research with Department of Energy (DOE) Support
  23. Application of Federalwide Assurance (FWA) Terms to UW-Madison Human Participants Research Policy
  24. Additional Requirements When Conducting Human Subjects Research with Department of Education (ED) Support
  25. Additional Requirements When Conducting Human Subjects Research with Department of Justice (DOJ) Support
  26. Additional Requirements When Conducting Human Subjects Research with Department of Defense (DOD) Support
  27. Compliance Monitoring and Quality Improvement
  28. Research with Adult Participants Lacking Capacity to Consent
  29. Obtaining and Documenting Informed Consent
  30. UW Post-Approval Monitors
  31. UW HRPP Quality Assurance
  32. Exempt Research
  33. Quality Assurance Committees
  34. HRPP and IRB Resources
  35. Institutional Official in Charge of HRPP
  36. IRB Authority and Independence
  37. IRB Composition and Quality Performance
  38. Noncompliance
  39. Unanticipated Problems
  40. Reporting of Suggestions and Concerns Regarding HRPP Performance and Function
  41. Suspension and Termination of Approved Research
  42. HRPP Education and Training
  43. IRB Meeting Minutes and Regulatory Documentation
  44. IRB Members’ Conflicts of Interest
  45. Investigating the Cause of Noncompliance and Implementing Corrective and Preventive Action (CAPA) Plans Guidance
  46. Review of Research Involving Vulnerable Participants
  47. Recruitment of Research Participants Guidance
  48. Instructions for Completing CITI Human Participants Research Training
  49. Research Participants
  50. Cross-Campus Human Research Protection Program (HRPP) Committee Charter
  51. Post-Approval Monitoring Program
  52. Issues in Human Subjects Research When State Law May Apply
  53. Retention of IRB Records
  54. Continuing Review: Submission and Review
  55. Study Closure
  56. Changes in Research Activities: Submission and Review
  57. IRB Reliance
  58. HRPP Newsletter - Spring 2018
  59. Protecting Research Participants Privacy Interests and Confidentiality of Data
  60. Evaluating the Scientific or Scholarly Merits of Proposed Research
  61. Equitable Selection of Research Participants Guidance
  62. Creation and Dissemination of Policies and Related Documentation
  63. De-Identified Publicly Available Datasets Guidance
  64. Reporting to Institutional and External Authorities
  65. Review of Data and Safety Monitoring in Research
  66. Maintenance of IRB Records
  67. ED/SBS IRB Principal Investigator Responsibilities
  68. List of Approved De-Identified Publicly Available Datasets
  69. NIH Genomic Data Sharing Policy for Human Data Guidance
  70. Conflicts of Interest of Non-UW-Madison Key Personnel
  71. FDA IRB Regulations (21 CFR 56)
  72. Campus IT Policies
  73. Single Institutional Review Board (IRB) for Multi-Site Federal Grants Policy
  74. Preventing Noncompliance Guidance
  75. Reportable Abuse and Neglect Guidance
  76. IRB Consultants Use and Conflict of Interest
  77. Common Rule (45 CFR 46)
  78. Use of Human Fetal Tissue in Research Policy Links
  79. OPRR Guidance on 45 CFR 46.101(b)(5): Exemption for Research and Demonstration Projects on Public Benefit and Service Programs
  80. IRB Analysis of Risks and Benefits of Research Guidance
  81. Developing an Internal Quality Assurance (QA) Program Guidance
  82. OHRP Guidance on Engagement of Institutions in Human Subjects Research
  83. UW-Madison HIPAA Program
  84. Student Research
  85. Considerations for Accepting or Ceding IRB Review Guidance
  86. Expert Review
  87. Office for Human Research Protections (OHRP) - IRB Knowledge of Local Research Context
  88. IRB Review of Study Resources
  89. Post Approval Monitoring Program Services
  90. Human Research Protection Program (HRPP) Newsletter - Spring 2017
  91. Human Research Protection Program (HRPP) Newsletter - Fall 2016
  92. Human Research Protection Program (HRPP) Newsletter - Spring 2016